Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Eiger BioPharmaceuticals, Inc. (EIGR)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
31 Oct 2023
KAWAS LEEN
10% Owner
Eiger BioPharmaceuticals, Inc.
(EIGR)
4,379,087+0%
24,332
$0.26
$6,374.80
BUY
31 Oct 2023
KAYNE RICHARD A
10% Owner
Eiger BioPharmaceuticals, Inc.
(EIGR)
5,375,225+5%
278,239
$0.26
$72,815.27
SELL
17 Mar 2023
Mayer Eldon C. III
Ex VP & Chief Commerc. Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
57,948-7%
4,395
$1.07
$4,703.96
BUY
23 Jan 2023
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
50,000+100%
50,000
$1.43
$71,580.00
SELL
29 Dec 2022
Murray Christine
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
11,000-31%
5,000
$1.22
$6,104.00
BUY
22 Dec 2022
Glenn Jeffrey S
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
182,355+121%
100,000
$1.28
$127,950.00
SELL
22 Dec 2022
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
21,000-51%
22,500
$1.17
$26,302.50
SELL
16 Aug 2022
Apelian David
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
11,000-31%
5,000
$9.81
$49,030.50
SELL
14 Mar 2022
Ryali Sriram
Chief Financial Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
41,566-5%
2,266
$5.60
$12,683.48
SELL
14 Mar 2022
Mayer Eldon C. III
Ex VP & Chief Commerc. Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
60,468-2%
1,657
$5.60
$9,274.73
SELL
7 Jan 2022
Mayer Eldon C. III
Ex VP & Chief Commerc. Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
46,125-3%
1,560
$4.95
$7,722.16
BUY
9 Apr 2021
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
36,500+7%
2,500
$8.49
$21,220.00
SELL
12 Mar 2021
Loh Evan
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
8,000-20%
2,000
$10.14
$20,280.00
SELL
8 Jan 2021
Mayer Eldon C. III
Ex VP & Chief Commerc. Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
35,810-4%
1,690
$11.68
$19,739.20
BUY
11 Aug 2020
Glenn Jeffrey S
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
500+105%
10,000
$11.46
$114,566.15
BUY
16 Mar 2020
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
30,000+3%
1,000
$4.95
$4,950.00
BUY
16 Mar 2020
Glenn Jeffrey S
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
66,355+82%
30,000
$5.03
$150,813.00
BUY
24 Jan 2020
Mayer Eldon C. III
Ex VP & Chief Commerc. Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
30,000+20%
5,000
$13.52
$67,602.50
BUY
10 Jan 2020
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
24,000+20%
4,000
$13.94
$55,760.00
BUY
25 Apr 2019
Cory David A
President and CEO, Director, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
66,346+0%
343
$11.26
$3,862.18
BUY
23 Apr 2019
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
20,000+33%
5,000
$11.10
$55,495.00
BUY
22 Apr 2019
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
15,000+50%
5,000
$11.05
$55,250.00
BUY
22 Apr 2019
Ryali Sriram
Chief Financial Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
1,250+100%
1,250
$11.08
$13,852.75
BUY
22 Apr 2019
Patton Stephana Eilene
See Remarks, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
4,000+33%
1,000
$11.03
$11,030.00
BUY
4 Feb 2019
Cory David A
President and CEO, Director, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
58,678+0%
227
$14.13
$3,207.51
BUY
20 Dec 2018
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
10,000+100%
5,000
$9.98
$49,900.00
BUY
6 Dec 2018
Dietz Thomas John
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
5,000+100%
5,000
$11.26
$56,300.00
BUY
29 Nov 2018
Mayer Eldon C. III
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
25,000+19%
4,000
$10.21
$40,840.00
BUY
26 Nov 2018
Mayer Eldon C. III
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
15,000+350%
21,000
$9.90
$207,997.50
SELL
18 Oct 2018
INTERWEST PARTNERS X LP
10% Owner
Eiger BioPharmaceuticals, Inc.
(EIGR)
1,388,792-14%
237,265
$12.06
$2,862,321.00
SELL
2 Apr 2018
Quan Joanne
Chief Medical Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
0-100%
4,000
$10.00
$40,000.00
BUY
1 Sep 2017
Glenn Jeffrey S
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
31,355+91%
15,000
$9.53
$142,950.00
BUY
17 Nov 2016
Glenn Jeffrey S
Director
Eiger BioPharmaceuticals, Inc.
(EIGR)
460+103%
15,460
$12.74
$196,884.00
BUY
18 Aug 2016
Vivo Ventures VI, LLC
10% Owner
Eiger BioPharmaceuticals, Inc.
(EIGR)
1,774,096+11%
187,500
$16.00
$3,000,000.00
BUY
18 Aug 2016
Cory David A
President and CEO, Director, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
58,451+2%
1,562
$15.70
$24,523.40
BUY
18 Aug 2016
Shaffer James P
Chief Business Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
5,620+125%
3,125
$15.70
$49,062.50
BUY
20 Jun 2016
WELCH JAMES H
Chief Financial Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
2,500+100%
2,500
$19.80
$49,489.60
BUY
13 Jun 2016
Shaffer James P
Chief Business Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
1,975+172%
1,250
$22.17
$27,717.80
BUY
19 May 2016
Shaffer James P
Chief Business Officer, Officer
Eiger BioPharmaceuticals, Inc.
(EIGR)
1,245+100%
1,245
$19.80
$24,652.55
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter